1 Adolph EF.Quantitative relations in the physio-logical constitutions of mammals.Science 1949; 109:5 79
2 Dedrick RL, Bischoff KB, Zaharko DS.Inter-species correla tion of plasma concerntration histry methot rexate.Cancer Chemo the rapy Reports, 1970;54:9 5
3 Bo xebaum H.Inter species scalling, allometry, physiological time, and the ground plan of phar-macokinetics.J Pharmacok. Biopharmaceut.1982; 10(2):201
4 Ritschel WA, Vachharajani NN, Johnson RD, et al.The allometric approach for interspecies scaling of pharmacokinetic parameters.Comp Biochem.physiol, 1992;103C(2):249
5 Krishnan K, Andersen M E.Interspecies scaling in pharmacokinetics.In:Rescigno A and Thakur AK,et al.New Trends in Pharmacokinetics.Plenum press, New York, 1991:203
6 Mahmood I, Balian JD.Interspecies scaling:A comparative study for the orediction of clearance and volume using two or more than two species. Life Science, 1996;5 9(7):579
7 Lashev LD, Pashov DA.Interspecies variations in plasma half-life of ampicillin, amoxy cillin, suphadimidine and sulphacetamide related to vari-ations in body mass.Res Vet Sci, 1992;5 3:1 60
8 Kirkwood JK, Widdowson M A.Interspecies vari-ation in the plasma half-life of oxytetracy cline in relation to bodyweight.Res Vet Sci, 1990;48:180
9 Lashev L, Pashov D, Tsvetanova Y.et al.Anal-ysis of there lationship between body mass and elimination half-life, total body clearance and vol-ume of distribution of several antibacterial drugs.J Vet Pharmacol The rap, 1997;20(Suppl 1):24
10 Riviere JE,Martin-Jimenez T, Sundlof S F.et al. Inter species allometric analysis of the comparative pharmacokinetics of 44 drugs acrossveterinary and laboratory animal species.J Vet Pharmacol Ther-ap, 1997;20(6):453
11 Mahmood I.Interspecies scaling:Predicting vol-umes, mean residence time and elimination half-life.Some suggestions.Jpharm Pharma col, 1998; 50(5):493
12 Hayton WL.Pharmacokinetic parameters for in-ter species scaling using allome tric techniques. Health Phys, 1989;57(Suppl 1):1 59
13 Box enbaum H.Interspecies pharmacokinetic scal-ing and the evolutionary-compa ative paradigm. Drug Metab Rev, 1984;1 5:1071
14 Boxenbaum H, Fertig JB.Scaling of antipyrine intrinsic clearance of unbound drug in 15 mamalian species.Eur J Drug Metab Pharmacok, 1984;9: 177
15 Mahmood I, Balian JD.Inter species scaling:Pre-div ting pharmacokinetic parameters of antiepiletic drugs in humans from animals with special empha-sis clearance.J Pharmaceut, Sci, 1996;8 5(4):4 11
16 Houston B.U tinity of in vitro drug met abolism data in predicting in vivometabolic clearance. Biochem Pharma co l, 1994;4 7:1469
17 Lave T, Dupin S, Schmitt C, et al.Integration of in vitrodat a into allometric scaling to predicThep-atic metabolic clearance in man:application to 10 extensively met abolized drugs J Pharm Sci, 1997; 86:5 84
18 Izumit, Enomoto S, Hosiyama K, et al.Pred-diction of the human Pharmacokinetics of troglita-zone, a new and extremsively metabolized antidia-betic agent, after oral administration, with an an-imal scale-up approach.J Pharmacol Exper Ther-ap, 1996;2 77(3):1630
19 Mitsuhashi Y, Sugiyama Y, Ozawa S.Prediction of ACNU plasmaconcentr ation-time profiles in humans by animal scale-up.Cancer Chemo ther. Pharmacol, 1990;27:2 0
20 Pashov DA, Lashev LD, Matev IM, et al.Inter-species comparisons of plasma half-life of trime thoprim in relation to bod mass.J Vet Pha r-macol The rap, 1997;2 0:48
21 Lave T, Levet-Trafit B, S chmitt-Hoffmann AH, et al.Interspecies scaling of interfer on distribution and comparison of allometric scaling with concen-trition-time transformations.J Pharmaceut S ci, 1995;8 4(11):1285 |
